74 related articles for article (PubMed ID: 25974615)
1. Efficacy of a microballoon catheter in transarterial chemoembolization of hepatocellular carcinoma using miriplatin, a lipophilic anticancer drug: Short-term results.
Ogawa M; Takayasu K; Hirayama M; Miura T; Shiozawa K; Abe M; Matsumoto N; Nakagawara H; Ohshiro S; Yamamoto T; Tanaka N; Moriyama M; Mutou H; Yamamoto Y; Irie T
Hepatol Res; 2016 Mar; 46(3):E60-9. PubMed ID: 25974615
[TBL] [Abstract][Full Text] [Related]
2. Durable complete response is achieved by balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma.
Shirono T; Iwamoto H; Niizeki T; Shimose S; Kajiwara A; Suzuki H; Kamachi N; Noda Y; Okamura S; Nakano M; Kuromatsu R; Murotani K; Koga H; Torimura T
Hepatol Commun; 2022 Sep; 6(9):2594-2604. PubMed ID: 35656864
[TBL] [Abstract][Full Text] [Related]
3. Impact of anticancer drugs on the therapeutic efficacy and side effects of hepatic arterial embolization for hepatocellular carcinoma.
Ihira H; Sonomura T; Makitani A; Makitani K; Fukuda K; Tanaka R; Koyama T; Sato H; Wan K; Ueno M; Ida Y; Kawai N; Minamiguchi H
JGH Open; 2023 Dec; 7(12):884-888. PubMed ID: 38162847
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety analysis of selective hepatic vein occlusion combined with arterial chemoembolization versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma.
Chang J; Wang H; Li J; Jin L
J Gastrointest Oncol; 2024 Apr; 15(2):710-720. PubMed ID: 38756643
[TBL] [Abstract][Full Text] [Related]
5. Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association.
Cho Y; Choi JW; Kwon H; Kim KY; Lee BC; Chu HH; Lee DH; Lee HA; Kim GM; Oh JS; Hyun D; Lee IJ; Rhim H;
J Liver Cancer; 2023 Sep; 23(2):241-261. PubMed ID: 37449302
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Balloon-Occluded Transcatheter Arterial Chemoembolization Followed by Surgical Resection: Pathological Evaluation of Necrosis.
Kim J; Gwon DI; Kim Y; Kim GH; Kim SH; Chu HH; Kim JH; Shin JH; Ko GY; Yoon HK
Diseases; 2023 Oct; 11(4):. PubMed ID: 37987260
[TBL] [Abstract][Full Text] [Related]
7. CT-Guided
Xu X; Ding Y; Pan T; Gao F; Huang X; Sun Q
Cancer Manag Res; 2021; 13():3317-3326. PubMed ID: 33883943
[TBL] [Abstract][Full Text] [Related]
8. Sustained release hypoxia-activated prodrug-loaded BSA nanoparticles enhance transarterial chemoembolization against hepatocellular carcinoma.
Hao Y; Zhu W; Li J; Lin R; Huang W; Ain QU; Liu K; Wei N; Cheng D; Wu Y; Lv W
J Control Release; 2024 Jun; 372():155-167. PubMed ID: 38879131
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter arterial chemotherapy with miriplatin for hepatocellular carcinoma patients with chronic renal failure: report of three cases.
Imai N; Ikeda K; Seko Y; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
Gut Liver; 2013 Mar; 7(2):246-51. PubMed ID: 23560163
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive discharge planning program on fatigue and functional status of patients with hepatocellular carcinoma undergoing transarterial chemoembolization: A randomized clinical controlled trial.
Yenjai N; Asdornwised U; Wongkongkam K; Pinjaroen N
Belitung Nurs J; 2022; 8(4):287-295. PubMed ID: 37546491
[TBL] [Abstract][Full Text] [Related]
11. Incidence and Risk Factors of Acute Ischemic Cholecystitis after Transarterial Chemoembolization: Correlation with Cone Beam CT Findings.
Kim JY; Oh JS; Chun HJ; Kim SH
J Korean Soc Radiol; 2024 Mar; 85(2):363-371. PubMed ID: 38617853
[TBL] [Abstract][Full Text] [Related]
12. Expanding the therapeutic armamentarium for advanced hepatocellular carcinoma: successful transarterial chemoembolization of peritoneal extrahepatic metastasis.
Brandi N; Giampalma E; Renzulli M
Clin J Gastroenterol; 2024 May; ():. PubMed ID: 38806884
[TBL] [Abstract][Full Text] [Related]
13. Post-Embolization Syndrome Complicated by Hypertensive Emergency and Severely Elevated Transaminases.
Kashfi S; Murdakhayev E; Rehmani R; Sharma S
Cureus; 2021 Jun; 13(6):e15446. PubMed ID: 34258113
[TBL] [Abstract][Full Text] [Related]
14. A case of pulmonary foreign body granuloma formation after transcatheter arterial chemoembolization for hepatocellular carcinoma.
Murata S; Nakamura M; Sasada S; Kirita K; Ishioka K; Takahashi S; Usui Y; Tsuchiya Y; Seki R
Respirol Case Rep; 2021 Nov; 9(11):e0863. PubMed ID: 34691477
[TBL] [Abstract][Full Text] [Related]
15. Concerns about how to simultaneously determine microvascular invasion and pathological response after transarterial chemoembolization before hepatocellular carcinoma surgery.
Paik KY
Hepatobiliary Surg Nutr; 2023 Oct; 12(5):815-817. PubMed ID: 37886184
[No Abstract] [Full Text] [Related]
16. Effect of Transarterial Chemotherapy on the Structure and Function of Gut Microbiota in New Zealand White Rabbits.
Bai L; Yan X; Qi P; Lv J; Song X; Zhang L
Biology (Basel); 2024 Mar; 13(4):. PubMed ID: 38666842
[TBL] [Abstract][Full Text] [Related]
17. Selective balloon-occluded transarterial chemoembolization for patients with one or two hepatocellular carcinoma nodules: Retrospective comparison with conventional super-selective TACE.
Irie T; Kuramochi M; Kamoshida T; Takahashi N
Hepatol Res; 2016 Feb; 46(2):209-14. PubMed ID: 26224032
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma tumor board: making sense of the technologies.
Abou-Alfa GK; Marrero J; Renz J; Lencioni R
Am Soc Clin Oncol Educ Book; 2015; ():e213-20. PubMed ID: 25993176
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization for hepatocellular carcinoma: An old method, now flavor of the day.
Boulin M; Delhom E; Pierredon-Foulongne MA; Cercueil JP; Guiu B
Diagn Interv Imaging; 2015 Jun; 96(6):607-15. PubMed ID: 25998996
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
